Acromegaly Cardiomyopathy

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-05-12
Clinical Trial Update: Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy [Phase 2]
Phase 2 trial evaluating response of acromegaly cardiomyopathy to cyclic GMP PDE5 inhibitors has completed.